Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Painful diabetic neuropathy is the most common cause of neuropathic pain. 0.075% topical capsaicin has been used to treat the pain, but there is no data in lower concentration. This is the efficacy and safety of 0.025% topical capsaicin in treatment of painful diabetic polyneuropathy.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Thammasat University
• Collaborator: Bangkok Drug company
• Treatments: Capsaicin

Criteria

Inclusion Criteria:

• History of type 2 Diabetes mellitus

• Peripheral neuropathy

• Stabilized on pain medication for at least one month

• No previous invasive intervention for pain relief

Exclusion Criteria:

• Local wound or skin abnormality in the applicable area

• Allergic to capsaicin

• Refuse to participate or give consent

• Has other significant disease or receive medication that may worsen neuropathy